Dřímal, J., Faberová, V., Schmidtová, L., Bednáriková, M., Dřímal, J. J. J., & Dřímal, D. The ACAT inhibitor VULM1457 significantly reduced production and secretion of adrenomedullin (AM) and down-regulated AM receptors on human hepatoblastic cells.
Chicago Style (17th ed.) CitationDřímal, J., V. Faberová, L. Schmidtová, M. Bednáriková, J. Ján Jr Dřímal, and D. Dřímal. The ACAT Inhibitor VULM1457 Significantly Reduced Production and Secretion of Adrenomedullin (AM) and Down-regulated AM Receptors on Human Hepatoblastic Cells.
MLA (9th ed.) CitationDřímal, J., et al. The ACAT Inhibitor VULM1457 Significantly Reduced Production and Secretion of Adrenomedullin (AM) and Down-regulated AM Receptors on Human Hepatoblastic Cells.
Warning: These citations may not always be 100% accurate.


